125 related articles for article (PubMed ID: 24338548)
1. Use of Cox regression with treatment status as a time-dependent covariate to re-analyze survival benefit excludes immortal time bias effect in patients with glioblastoma who received prolonged adjuvant treatment with valganciclovir.
Söderberg-Naucler C; Peredo I; Rahbar A; Hansson F; Nordlund A; Stragliotto G
Int J Cancer; 2014 Jul; 135(1):248-9. PubMed ID: 24338548
[No Abstract] [Full Text] [Related]
2. Immortal time bias in retrospective analysis: is there a survival benefit in patients with glioblastoma who received prolonged treatment of adjuvant valganciclovir?
Liu CJ; Hu YW
Int J Cancer; 2014 Jul; 135(1):250-1. PubMed ID: 24338590
[No Abstract] [Full Text] [Related]
3. Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study.
Stragliotto G; Rahbar A; Solberg NW; Lilja A; Taher C; Orrego A; Bjurman B; Tammik C; Skarman P; Peredo I; Söderberg-Nauclér C
Int J Cancer; 2013 Sep; 133(5):1204-13. PubMed ID: 23404447
[TBL] [Abstract][Full Text] [Related]
4. VIGAS and beyond: the impact of HCMV-infection and its treatment in glioblastoma.
Ottenhausen M; Bodhinayake I; Schaefer PM; Boockvar JA
Neurosurgery; 2014 Feb; 74(2):N23-4. PubMed ID: 24435151
[No Abstract] [Full Text] [Related]
5. Does valganciclovir have a role in glioblastoma therapy?
Cobbs CS
Neuro Oncol; 2014 Mar; 16(3):330-1. PubMed ID: 24523453
[No Abstract] [Full Text] [Related]
6. Cytomegalovirus and glioblastoma: a review of evidence for their association and indications for testing and treatment.
Solomon IH; Ramkissoon SH; Milner DA; Folkerth RD
J Neuropathol Exp Neurol; 2014 Nov; 73(11):994-8. PubMed ID: 25289896
[TBL] [Abstract][Full Text] [Related]
7. Controversies in neuro-oncology: does valganciclovir have a role in the treatment of high-grade gliomas?
Wen PY
Neuro Oncol; 2014 Mar; 16(3):329. PubMed ID: 24523452
[No Abstract] [Full Text] [Related]
8. [Questionable effect of antiviral therapy in malignant brain tumors].
Kinhult S; Werlenius K; Hallbeck AL; Nyström PW; Männikkö V; Johansson M
Lakartidningen; 2014 Apr 29-May 13; 111(18-19):809. PubMed ID: 24855749
[No Abstract] [Full Text] [Related]
9. CMV infection and glioma, a highly controversial concept struggling in the clinical arena.
Wick W; Platten M
Neuro Oncol; 2014 Mar; 16(3):332-3. PubMed ID: 24523454
[No Abstract] [Full Text] [Related]
10. [Inconclusive data].
Kinhult S; Werlenius K; Hallbeck AL; Nyström PW; Männikkö V; Johansson M
Lakartidningen; 2014 Jul 2-15; 111(27-28):1192. PubMed ID: 25162111
[No Abstract] [Full Text] [Related]
11. [Questionable debate on antiviral therapy in malignant glioblastoma].
Stragliotto G; Peredo I; Rahbar A; Andersson M; Nauclér CS
Lakartidningen; 2014 Jul 2-15; 111(27-28):1191-2; author reply 1192. PubMed ID: 25162110
[No Abstract] [Full Text] [Related]
12. VIGAS and beyond: the impact of HCMV-infection and its treatment in glioblastoma.
Ottenhausen M; Bodhinayake I; Schaefer PM; Boockvar JA
Neurosurgery; 2014 Apr; 74(4):N17-8. PubMed ID: 24642991
[No Abstract] [Full Text] [Related]
13. Brain cancer. A viral link to glioblastoma?
Miller G
Science; 2009 Jan; 323(5910):30-1. PubMed ID: 19119195
[No Abstract] [Full Text] [Related]
14. The legend of cytomegalovirus and glioblastoma lives on.
Weller M; Soffietti R; Brada M
Neuro Oncol; 2014 Jan; 16(1):166. PubMed ID: 24311642
[No Abstract] [Full Text] [Related]
15. Challenging cytomegalovirus data in glioblastoma.
Wick W; Wick A; Platten M
Neuro Oncol; 2014 Jan; 16(1):165. PubMed ID: 24353326
[No Abstract] [Full Text] [Related]
16. A prospective assessment of valganciclovir for the treatment of cytomegalovirus infection and disease in transplant recipients.
Humar A; Siegal D; Moussa G; Kumar D
J Infect Dis; 2005 Oct; 192(7):1154-7. PubMed ID: 16136456
[TBL] [Abstract][Full Text] [Related]
17. Valganciclovir in patients with glioblastoma.
Hellstrand K; Martner A; Bergström T
N Engl J Med; 2013 Nov; 369(21):2066. PubMed ID: 24256397
[No Abstract] [Full Text] [Related]
18. Valganciclovir in patients with glioblastoma.
Söderberg-Nauclér C; Peredo I; Stragliotto G
N Engl J Med; 2013 Nov; 369(21):2066-7. PubMed ID: 24256396
[No Abstract] [Full Text] [Related]
19. Survival in patients with glioblastoma receiving valganciclovir.
Söderberg-Nauclér C; Rahbar A; Stragliotto G
N Engl J Med; 2013 Sep; 369(10):985-6. PubMed ID: 24004141
[No Abstract] [Full Text] [Related]
20. Incidence and characterization of cytomegalovirus resistance mutations among pediatric solid organ transplant patients who received valganciclovir prophylaxis.
Martin M; Goyette N; Ives J; Boivin G
J Clin Virol; 2010 Apr; 47(4):321-4. PubMed ID: 20138805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
